Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
319 stocks worldwide match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| BCYC | Bicycle Therapeutics plc | Oncology | $304.03M | $4.36 | −52.45% | +10.53% |
| PYXS | Pyxis Oncology, Inc. | Oncology | $278.58M | $3.34 | −39.82% | +14.78% |
| WHWK | Whitehawk Therapeutics, Inc. | Oncology | $275.92M | $4.84 | −11.92% | +31.52% |
| ALXO | ALX Oncology Holdings Inc. | Oncology |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| $273.79M |
| $1.98 |
| −25.56% |
| −0.50% |
| CGEN | Compugen Ltd. | Oncology | $271.86M | $2.84 | −12.35% | +25.66% |
| GLSI | Greenwich LifeSciences, Inc. | Oncology | $267.58M | $18.23 | −46.54% | +35.54% |
| TNG.PA | Transgene SA | Oncology | $263.11M | 0.81 EUR | −46.27% | +12.57% |
| ADAG | Adagene Inc. | Oncology | $258.50M | $3.85 | −20.62% | +3.22% |
| MGNX | MacroGenics, Inc. Common Stock | Oncology | $257.35M | $4.04 | −20.47% | +4.94% |
| 0IV3.L | Geron Corporation | Oncology | $255.34M | $1.53 | −23.67% | −0.97% |
| IPHA | Innate Pharma S.A. | Oncology | $253.56M | $2.16 | −20.30% | +28.57% |
| SPL.AX | Starpharma Holdings Limited | Oncology | $248.56M | 0.73 AUD | −11.04% | −2.03% |
| IDD.DE | Innate Pharma S.A. | Oncology | $243.27M | 1.78 EUR | −15.24% | +12.80% |
| IPH.PA | Innate Pharma S.A. | Oncology | $240.15M | 1.88 EUR | −19.40% | +19.01% |
| TARA | Protara Therapeutics, Inc. | Oncology | $231.06M | $3.91 | −50.00% | −0.76% |
| CHRS | Coherus Oncology, Inc. | Oncology | $224.03M | $1.45 | −44.57% | +0.69% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | Oncology | $218.56M | $11.30 | −45.04% | +24.38% |
| NBP | NovaBridge Biosciences | Oncology | $216.26M | $1.87 | −72.46% | +6.86% |
| CUE | Cue Biopharma, Inc. | Oncology | $209.58M | $28.85 | −36.59% | −4.63% |
| MOLN | Molecular Partners AG | Oncology | $170.46M | $4.45 | −16.98% | +16.19% |
| MENS | Jyong Biotech Ltd. | Oncology | $170.30M | $2.24 | −96.66% | −6.28% |
| KZIA | Kazia Therapeutics Limited | Oncology | $166.83M | $14.60 | −16.09% | +15.05% |
| BINV.ST | BioInvent International AB (publ) | Oncology | $162.35M | 24.30 SEK | −35.97% | +5.42% |
| OKUR | OnKure Therapeutics, Inc. | Oncology | $155.52M | $3.80 | −29.37% | −3.80% |
| ASRT | Assertio Holdings Inc | Oncology | $151.86M | $23.50 | 0.00% | 0.00% |
| INDP | Indaptus Therapeutics, Inc. | Oncology | $145.90M | $1.14 | −86.70% | −34.10% |
| 0IMT.L | Photocure ASA | Oncology | $144.18M | 53.80 NOK | −32.41% | +0.35% |
| SCLP.L | Scancell Holdings plc | Oncology | $136.80M | 9.70 GBP | −67.12% | −2.02% |
| HURA | TuHURA Biosciences, Inc. | Oncology | $135.74M | $2.13 | −37.90% | 0.00% |
| HPHA.DE | Heidelberg Pharma AG | Oncology | $135.27M | 2.52 EUR | −45.69% | −2.70% |
| ADCT | ADC Therapeutics SA | Oncology | $134.05M | $1.05 | −78.92% | −5.41% |
| BDTX | Black Diamond Therapeutics, Inc. | Oncology | $130.42M | $2.27 | −54.05% | +28.98% |
| 0RU5.L | Oncoinvent ASA | Oncology | $128.23M | 85.40 NOK | −4.04% | 0.00% |
| LIXT | Nomad Power Solutions Inc | Oncology | $125.36M | $4.18 | −50.12% | −5.64% |
| CTX.WA | Captor Therapeutics Spolka Akcyjna | Oncology | $124.97M | 74.00 PLN | −17.04% | −0.80% |
| GNLX | Genelux Corporation | Oncology | $123.52M | $2.73 | −68.01% | −6.51% |
| ANIX | Anixa Biosciences, Inc. | Oncology | $122.65M | $3.61 | −33.97% | +2.41% |
| NTHI | NeOnc Technologies Holdings, Inc. | Oncology | $122.16M | $4.56 | −64.90% | +30.66% |
| 0RDB.L | Oryzon Genomics S.A. | Oncology | $121.50M | 2.87 EUR | −28.25% | +2.06% |
| RVU.WA | Ryvu Therapeutics S.A. | Oncology | $115.61M | 18.40 PLN | −42.32% | +22.67% |
| 4889.T | Renascience Inc. | Oncology | $112.48M | 1,309.00 JPY | −44.11% | −8.59% |
| FARN.L | Faron Pharmaceuticals Oy | Oncology | $110.28M | 41.00 GBP | −82.92% | −4.65% |
| ONCY | Oncolytics Biotech Inc. | Oncology | $109.10M | $0.86 | −43.34% | +8.30% |
| HBP.TO | Helix BioPharma Corp. | Oncology | $106.76M | 1.94 CAD | −64.07% | +33.79% |
| 4575.T | CanBas Co., Ltd. | Oncology | $103.86M | 840.00 JPY | −46.08% | +23.17% |
| AMAN | Amanat Acquisition Corp | Oncology | $103.52M | $10.70 | −0.47% | +5.42% |
| JATT | JATT II Acquisition Corp. | Oncology | $93.68M | $12.01 | −49.45% | +7.81% |
| ACRV | Acrivon Therapeutics, Inc. | Oncology | $93.42M | $2.08 | −41.57% | +35.06% |
| 4579.T | RaQualia Pharma Inc. | Oncology | $93.23M | 568.00 JPY | −61.23% | +25.39% |
| OSE.PA | OSE Immunotherapeutics SA | Oncology | $88.75M | 3.21 EUR | −58.29% | −0.19% |
| MAIA | MAIA Biotechnology, Inc. | Oncology | $84.56M | $1.39 | −56.43% | +12.10% |
| VRCA | Verrica Pharmaceuticals Inc. | Oncology | $84.35M | $4.91 | −50.01% | −9.07% |
| 0QW5.L | Heidelberg Pharma AG | Oncology | $84.14M | 2.46 EUR | −45.58% | 0.00% |
| CTOR | Citius Oncology, Inc. | Oncology | $83.24M | $0.79 | −65.02% | +45.49% |
| 0J4V.L | Heron Therapeutics, Inc. | Oncology | $82.85M | $0.31 | −80.47% | −3.55% |
| POLB.L | Poolbeg Pharma PLC | Oncology | $82.41M | 8.60 GBP | −6.52% | +36.51% |
| 4888.T | Stella Pharma Corporation | Oncology | $80.24M | 353.00 JPY | −64.52% | +18.06% |
| 0QXX.L | Molecular Partners AG | Oncology | $79.34M | 3.51 CHF | −10.91% | +2.33% |
| ELTX | Elicio Therapeutics, Inc. | Oncology | $78.32M | $2.98 | −81.38% | +1.02% |
| APLM | Apollomics, Inc. | Oncology | $76.75M | $26.20 | −37.80% | +43.80% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.